Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

NCT00632463 is registered in ClinicalTrials.gov with ADMA Biologics, Inc. as lead sponsor.

NCT NCT00632463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00632463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness
Lead sponsor
ADMA Biologics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
May 31, 2010
Enrollment
21 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

lower respiratory tract infection, upper respiratory tract infection